Chung Yong-ji

Chung Yong‑ji is a South Korean businessman. The founder and CEO of the biotechnology company, Forbes estimated his net worth at in February 2023.

Education

Chung attained his Bachelor of Science in Genetic Engineering from Sungkyunkwan University. He then pursued a master’s degree in biology at the University of Texas at San Antonio, and in 1996 completed a PhD in molecular biology at Cornell University. Following that, he conducted postdoctoral research in Breast Oncology at the Northwestern University Feinberg School of Medicine from 2000 to 2001.

Career

Chung founded Caregen in August 2001, focusing on peptide technology research and development.
Caregen went public on the KOSDAQ in 2015, raising approximately $160 million. As of late 2023, Chung holds roughly 64% of the company.